New implanted defibrillator works well without touching heart

American Heart Association Rapid Access Journal Report

2013-08-27

(Press-News.org) A new type of defibrillator implanted under the skin can detect dangerously abnormal heart rhythms and deliver shocks to restore a normal heartbeat without wires touching the heart, according to research in the American Heart Association journal, Circulation. The subcutaneous implantable cardiac defibrillator (S-ICD®) includes a lead placed under the skin along the left side of the breast bone. Traditional implantable cardiac defibrillators (ICDs) include electrical conducting wires inserted into blood vessels that touch the heart. ICDs can greatly reduce the risk of death in patients at high risk for sudden cardiac arrest. Physicians insert the new device without X-ray guidance, and have reduced concerns about broken lead wires, vessel damage, vessel infection and scarring that make traditional device removal difficult. "Defibrillation has repeatedly proven to be a great asset in prolonging the lives of cardiac patients, but there are still some risks to address," said Martin C. Burke, D.O., senior author of the study and a professor of medicine and director of the Heart Rhythm Center at the University of Chicago. "This new system was developed over a dozen years to combine some of the best aspects of traditional implanted ICDs and external defibrillators." In the 33-site study, 314 of 330 patients (average age 52) evaluated had the S-ICD® implanted. During an average 11-month follow-up, 21 patients spontaneously developed 38 episodes of ventricular fibrillation or ventricular tachycardia. All were successfully restored to a normal heart rhythm. In addition, 41 patients (13.1 percent) received shocks that were inappropriate because they weren't preceded by a dangerous heart rhythm. The study surpassed goals set by the U.S. Food and Drug Administration for evaluating the safety and effectiveness of the new device: Ninety-nine percent of the S-ICD® patients remained free of complications 180 days following implantation, compared with a 79 percent goal. When tested by a purposely-induced abnormal rhythm following implantation, the S-ICD® was 100 percent effective at consistently detecting and reversing ventricular fibrillation. The FDA goal is 88 percent. The S-ICD® has been available in Europe and New Zealand since 2009 and received FDA approval in the United States in 2012. Participants in the study, along with new patients, will be followed to assess the performance of the new device over time. Patients with certain types of pacemakers, and those with symptoms related to a slow heartbeat, should not use an S-ICD®. Data from the registries will be used to determine the range of patients who might be helped by the device, including those on dialysis and those with birth defects involving the heart. "The S-ICD® is not a replacement for other defibrillators," Burke said. "For some patients it will be ideal, for others inappropriate, and the vast proportion in the middle will be able to select the type of system they want," Burke said. A comparison between a traditional ICD and the S-ICD® is underway. ### Co-authors are Raul Weiss, M.D.; Bradley P. Knight, M.D.; Michael R. Gold, M.D., Ph.D.; Angel R. Leon, M.D.; John M. Herre, M.D.; Margaret Hood, M.B., Ch.B.; Mayer Rashtian, M.D.; Mark Kremers, M.D.; Ian Crozier, M.B., Ch.B.; Kerry L. Lee, Ph.D.; and Warren Smith, M.D. Author disclosures are on the manuscript. The study was funded by Cameron Health Inc. and then by Boston Scientific Corporation following its acquisition of Cameron Health Inc. For the latest heart and stroke news, follow us on Twitter: @HeartNews. For updates and new science in Circulation, follow @CircAHA. Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association's policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at http://www.heart.org/corporatefunding.

ELSE PRESS RELEASES FROM THIS DATE:

Sea otters promote recovery of seagrass beds

2013-08-27

Scientists studying the decline and recovery of seagrass beds in one of California's largest estuaries have found that recolonization of the estuary by sea otters was a crucial factor in the seagrass comeback. Led by researchers at the University of California, Santa Cruz, the study will be published in the Proceedings of the National Academy of Sciences the week of August 26. Seagrass meadows, which provide coastal protection and important habitat for fish, are declining worldwide, partly because of excessive nutrients entering coastal waters in runoff from farms and ...

Maintain, don't gain: A new way to fight obesity

2013-08-27

DURHAM, N.C. -- Programs aimed at helping obese black women lose weight have not had the same success as programs for black men and white men and women. But new research from Duke University has found that a successful alternative could be a "maintain, don't gain" approach. The study, which appears in the Aug. 26 issue of JAMA Internal Medicine, compared changes in weight and risk for diabetes, heart disease or stroke among 194 premenopausal black women, aged 25-44. They were recruited from Piedmont Health's six nonprofit community health centers in a multi-county area ...

Disabling enzyme reduces tumor growth, cripples cancer cells, finds new study

2013-08-27

Berkeley — Knocking out a single enzyme dramatically cripples the ability of aggressive cancer cells to spread and grow tumors, offering a promising new target in the development of cancer treatments, according to a new study by researchers at the University of California, Berkeley. The paper, to be published Monday, Aug. 26, in the journal Proceedings of the National Academy of Sciences, sheds new light on the importance of lipids, a group of molecules that includes fatty acids and cholesterol, in the development of cancer. Researchers have long known that cancer ...

Immune system, skin microbiome 'complement' one another, finds Penn Medicine study

2013-08-27

PHILADELPHIA – Researchers from the Perelman School of Medicine at the University of Pennsylvania demonstrate for the first time that the immune system influences the skin microbiome. A new study found that the skin microbiome – a collection of microorganisms inhabiting the human body – is governed, at least in part, by an ancient branch of the immune system called complement. In turn, it appears microbes on the skin tweak the complement system, as well as immune surveillance of the skin. They found that complement may, in part, be responsible for maintaining a diverse ...

Comprehensive Parkinson's biomarker test has prognostic and diagnostic value

2013-08-27

PHILADELPHIA - Perelman School of Medicine researchers at the University of Pennsylvania report the first biomarker results reported from the Parkinson's Progression Markers Initiative (PPMI), showing that a comprehensive test of protein biomarkers in spinal fluid have prognostic and diagnostic value in early stages of Parkinson's disease. The study is reported in JAMA Neurology. Compared to healthy adults, the study found that people with early Parkinson's had lower levels of amyloid beta, tau and alpha synuclein in their spinal fluid. In addition, those with lower ...

Terminology used to describe preinvasive breast cancer may affect patients' treatment preferences

2013-08-27

When ductal carcinoma in situ (DCIS, a preinvasive malignancy of the breast) is described as a high-risk condition rather than cancer, more women report that they would opt for nonsurgical treatments, according to a research letter by Zehra B. Omer, B.A., of Massachusetts General Hospital—Institute for Technology Assessment, Boston, and colleagues. A total of 394 healthy women without a history of breast cancer participated in the study and were presented with three scenarios that described a diagnosis of DCIS as noninvasive breast cancer, breast lesion, or abnormal cells. ...

Intervention appears effective to prevent weight gain among black women

2013-08-27

An intervention not focused on weight loss was effective for weight gain prevention among socioeconomically disadvantaged black women, according to a report published by JAMA Internal Medicine, a JAMA Network publication. Promoting clinically meaningful weight loss among black women has been a challenge. Compared to white women, "black women have higher rates of body weight satisfaction, fewer social pressures to lose weight, and sociocultural norms that tolerate heavier body weights," according to the study background. "New weight management strategies are necessary ...

Thyroid ultrasound imaging may be useful to reduce biopsies in patients with low risk of cancer

2013-08-27

Thyroid ultrasound imaging could be used to identify patients who have a low risk of cancer for whom biopsy could be postponed, according to a study by Rebecca Smith-Bindman, M.D., of the University of California, San Francisco, and colleagues. The retrospective case-control study of 8,806 patients who underwent 11,618 thyroid ultrasound imaging examinations from January 2000 through March 2005 included 105 patients diagnosed as having thyroid cancer. Thyroid nodules were common in patients diagnosed as having cancer (96.9 percent) and patients not diagnosed as having ...

Extremely preterm infants and risk of developing neurodevelopmental impairment later in childhood

2013-08-27

A meta-analysis of previously reported studies by Gregory P. Moore, M.D., F.R.C.P.C., of The Ottawa Hospital, Ontario, Canada, and colleagues examined the rate of moderate to severe and severe neurodevelopmental impairment by gestational age in extremely preterm survivors followed up between ages 4 and 8 years, and determined whether there is a significant difference in impairment rates between the successive weeks of gestation of survivors. The search of English-language publications found nine studies that met inclusion criteria of being published after 2004, a prospective ...

Interpretation of do-not-resuscitate order appears to vary among pediatric physicians

2013-08-27

Clinicians use the do-not-resuscitate (DNR) order not only as a guide for therapeutic decisions during a cardiopulmonary arrest but also as a surrogate for broader treatment directives, according to a study by Amy Sanderson M.D., of Boston Children's Hospital, M.A., and colleagues. A total of 107 physicians and 159 nurses responded to a survey regarding their attitudes and behaviors about DNR orders for pediatric patients. There was substantial variability in the interpretation of the DNR order. Most clinicians (66.9 percent) reported that they considered that a DNR order ...

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

New implanted defibrillator works well without touching heart

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: